Background: H. Pylori infection in end stage renal disease (ESRD) patients can have a potential impact on morbidity and mortality of these patients. Objectives: This work is done to know the frequency of H. pylori infection in ESRD paediatric patients in comparison with healthy-matched children and to assess the impact of H. pylori on the disease status of these patients.
INTRODUCTION
Helicobăcter Pylori (H. pylori) is a gram-negative bacillus that resides usually in the gastric mriucosa and represents the most common chronic bacterial infection' ). Although H. pylori is widely seen, it is accepted as an etiologic factor in peptic ulcers, chronic gastritis, dyspepsia, gastric cancer, and mucosal-associated lymphoid tissue lymphomaa 2 . It is highly prevalent in low-income countries and colonization usually happens early in lifet 3) .
Upper gastro-intestinal (GI) abnormalities are common in end stage renal disease .
AIM OF THE WORK
This study was designed to know the frequency of occurrence of H. pylori infection in ESRD children in comparison with healthy-matched children, identify the relationship between H. pylori infection and the gastrointestinal symptoms in ESRD, to study the relationship between H. pylori infection and the iron status and to know the association between Hepatitis C virus (HCV) and H. pylori infection in these patients.
PATIENTS AND METHODS
This is a cross-sectional study conduc- A significant difference between the two groups was found in the transferrer saturation index (p -0.033) but not in the hemoglobin, iron. TІBС or ferritin. The influence of the presence of f1. pylori on the routine laboratory tests done to ESRD patients is shown in Table 2 . Predialysis urea, albumin, calcium and phosphorus showed non-significant difference between the K pylori positive cases and H. pylori negative cases.
A significant correlation was noticed between urea and serum iron in positive cases (r = 0.477, p = 0.045) and between urea and serum ferritin in negative cases. (r = -0.466. p = 0.038).
Screening for HCV revealed eleven positive cases among the ESRD patients (28.9%). 7/18 (38.9%) of the H. pylori positive cases had HCV versus 4/20 (20%) in H. pylori negative cases but this comparison was non-significant (p == 0.288). 
DISCUSSION
The current study showed that the prevalence of H. pylori was significantly higher in ESRD patients than in the healthy subjects. Despite this, it seems to have minimal impact on their current disease status as evidenced by the non-significant difference in the occurrence of GI symptoms, growth parameters, haematological status and biochemical data.
Worldwide, H. pylori prevalence in children ranges from under 10% to almost 80%, being high in developing countries 1 3^.
In ESRD pediatric patients, the prevalence of H. pylori is variable among the different studies ranging from around 25%t 10) to around 65% in other studiest 6,14>
In our study, 47.4% of the ESRD patients harbored H. pylori compared to only 18% of normal children (p = 0.0064). In uremic patients, many reports suggested a higher frequency of H. pylori infectiont 15 ' 16). However, some authors found lower frequency of H. pylori infection with uremia 117.19 due to inhibition of H. pylori by other bacterial colonizationt l8 > or by the toxic waste product accumulation in severe uremia (19) .
There was no age or gender related differences between the H. pylori positive and negative cases in our study as well as in other studies done on ESRD patients( 14,2°). However, male predominance was noticed among apparently healthy children in urban Kampala°. Higher prevalence of H. pylori was noticed, as the age gets older, in ESRD patientst
4.10)
Non-significant differences in dialysis duration were noticed in our study as well as in other studies (1Q • 20) . However, longer dialysis duration was associated with lower H pylori prevalence in some studies (14, 21, 22 
